v3.26.1
Organization and Description of the Business (Details Narrative) - USD ($)
6 Months Ended
Feb. 12, 2026
Feb. 10, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Accumulated deficit     $ 416,311,000   $ 400,761,000
Cash and cash equivalents     17,756,000   11,583,000
Restricted cash     972,000   $ 1,300,000
Offering expenses     $ 1,368,000 $ 487,000  
Bio Rad Laboratories Inc [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Global strategic partnership agreement period     10 years    
Private Placement [Member] | Common Stock [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from private placement $ 26,000,000 $ 29,100,000      
Offering expenses 1,400,000 487,000      
Net proceeds from issuance of private placement $ 24,600,000 $ 28,700,000